Endeavour Silver -9.1% in early trading Tuesday after saying it will upsize its previously announced bought deal of common ...

The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.

Shares of Moderna ( MRNA -9.35%) are falling on Monday. The company's stock lost 7.9% as of 1:30 p.m. ET and was down as much ...

The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible within two business days, through SEDAR+ All dollar amounts are stated in United States (U.S.) Dollars unless ...

Already reeling from years of market chaos, the announced departure of CBER chief Peter Marks sent a ripple across biopharma ...

Further details concerning the Offering are set out in ECN Capital’s prospectus supplement dated March 14, 2025, available on SEDAR+ at www.sedarplus.com. About ECN Capital Corp.

The value of global syndicated lending declined in the first quarter, according to new data from LSEG Data & Analytics. The ...

Analysts at BMO Capital Markets expressed that this departure might undermine the FDA's mission, stressing that the agency's independence is vital for delivering safe and effective treatments. As the ...

Ashland Inc. (NYSE:ASH – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six ratings firms that are ...

American Century Companies Inc. cut its stake in shares of Equitable Holdings, Inc. (NYSE:EQH – Free Report) by 21.6% in the ...

Analysts at financial firm Cantor Fitzgerald are urging President Donald Trump to rethink his appointment of Robert F. Kennedy Jr. as Secretary of Health and Human Services.

Biotech stocks plunge after Dr. Peter Marks resigns from FDA, citing disputes with RFK Jr. over vaccines and drug approvals.